Literature DB >> 28416574

A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A.

Neil M Otto1, William G McDowell1, Deborah M Dickey1, Lincoln R Potter2.   

Abstract

Multisite phosphorylation is required for activation of guanylyl cyclase (GC)-A, also known as NPR-A or NPR1, by cardiac natriuretic peptides (NPs). Seven chemically identified sites (Ser-487, Ser-497, Thr-500, Ser-502, Ser-506, Ser-510, and Thr-513) and one functionally identified putative site (Ser-473) were reported. Single alanine substitutions for Ser-497, Thr-500, Ser-502, Ser-506, and Ser-510 reduced maximal velocity (Vmax), whereas glutamate substitutions had no effect or increased Vmax Ala but not Glu substitution for Ser-497 increased the Michaelis constant (Km) approximately 400%. A GC-A mutant containing Glu substitutions for all seven chemically identified sites (GC-A-7E) had a Km approximately 10-fold higher than phosphorylated wild-type (WT) GC-A, but one additional substitution for Ser-473 to make GC-A-8E resulted in the same Vmax, Km, and EC50 as the phosphorylated WT enzyme. Adding more glutamates to make GC-A-9E or GC-A-10E had little effect on activity, and sequential deletion of individual glutamates in GC-A-8E progressively increased the Km Double Ala substitutions for Ser-497 and either Thr-500, Ser-510 or Thr-513 in WT-GC-A increased the Km 23- to 70-fold but the same mutations in GC-A-8E only increased the Km 8-fold, consistent with one site affecting the phosphorylation of other sites. Phosphate measurements confirmed that single-site Ala substitutions reduced receptor phosphate levels more than expected for the loss of a single site. We conclude that a concentrated region of negative charge, not steric properties, resulting from multiple interdependent phosphorylation sites is required for a GC-A conformation capable of transmitting the hormone binding signal to the catalytic domain.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28416574      PMCID: PMC5452060          DOI: 10.1124/mol.116.107995

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

3.  Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.

Authors:  L R Potter
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

Review 4.  Guanylyl cyclase structure, function and regulation.

Authors:  Lincoln R Potter
Journal:  Cell Signal       Date:  2011-09-10       Impact factor: 4.315

5.  Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue: a possible mechanism of heterologous desensitization.

Authors:  L R Potter; T Hunter
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor.

Authors:  L R Potter; T Hunter
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor.

Authors:  L R Potter; T Hunter
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization.

Authors:  L R Potter; D L Garbers
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 9.  Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

Authors:  Scott A Hubers; Nancy J Brown
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

10.  Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  Sci Signal       Date:  2012-09-04       Impact factor: 8.192

View more
  3 in total

1.  Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice.

Authors:  Brandon M Wagner; Jerid W Robinson; Chastity L Healy; Madeline Gauthier; Deborah M Dickey; Siu-Pok Yee; John W Osborn; Timothy D O'Connell; Lincoln R Potter
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.191

2.  S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia.

Authors:  Chang-Ki Oh; Nima Dolatabadi; Piotr Cieplak; Maria T Diaz-Meco; Jorge Moscat; John P Nolan; Tomohiro Nakamura; Stuart A Lipton
Journal:  J Neurosci       Date:  2022-02-15       Impact factor: 6.709

3.  The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.

Authors:  Aaron B Edmund; Timothy F Walseth; Nicholas M Levinson; Lincoln R Potter
Journal:  Sci Signal       Date:  2019-01-29       Impact factor: 9.517

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.